Health Condition 1: K801- Calculus of gallbladder with othercholecystitis
Conditions
Interventions
Intervention1: Effectiveness of intravenous rabeprazole premedication on gastric fluid pH and volume change in patients undergoing laparoscopic cholecystectomy: GROUP-B Study group Patients receiving
Sponsors
VCSGGMS and RI Srikot Srinagar Garhwal Uttarakhand
Eligibility
Inclusion criteria
Inclusion criteria: Patient with American Society Of Anaesthesia Grade 1 and 2 undergoing laproscopic cholecystectomy under general anaesthesia
Exclusion criteria
Exclusion criteria: EXCLUSION CRITERIA- Patient with gastric reflux, peptic ulcer hiatal hernia,liver disease with deranges liver function, hypersensitivity to pantoprazole will be excluded from study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A)To study effect/ action of intravenous rabeprazole on gastric pH and volume during laparoscopic cholecystectomy. Timepoint: The gastric aspirates for pH (3ML) and volume and measurement will be collected through Ryle’s tube (16G).Colour of samples will be noted. i) At the end of 8 hrs of fasting period before inj rabeprazole-TIME-0 ii) Post Induction 5minutes Before CO2 insufflation iii) 5 minutes Post CO2 Inflation than Half hrly perioperatively iV) Post CO2 deflation 5 ,10 ,15minuts and 30 minutes perioperatively V) I/2 hr & 1hr after extubation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of Perioperative duodenal gastric regurgitation during laparoscopic cholecystectomy C)Postoperative nausea vomiting Timepoint: i)At the end of fasting period before inj rabeprazole ii)Post Induction Before CO2 insufflation iii)Post CO2 Inflation Halfhrly perioperatively iV)Post CO2 deflation perioperatively V)1/2 hr & 1hr after extubation. | — |
Countries
India
Contacts
Public ContactDr Satyendra Yadav
Department Of Anaesthesia VCSGGMS and RI
Outcome results
None listed